Schizophrenia: how should we look at it?

Abstract

Get full access to this article

View all access options for this article.

References

Aston-Jones G. , Akaoka H. , Charléty P. , Chouvet G. (1991) Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J Neurosci 11: 760-769

Benes F.M. (1995) Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of schizophrenic brain. Archs Gen Psychiat 52: 1015-1017

Chiodo L.A. , Bunney S.B. (1983) Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3: 1607-1619

Deutch A.Y. (1992) The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm 36 (Suppl.): 61-89

Dewey S.L. , Smith G.S. , Logan J. , Alexoff D. , DingY.S. , King P. , Pappas N. , Brodie J.D. , Ashby C R J (1995) Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neurosci 15: 821-829

Ereshefsky L. (1995) Treatment strategies for schizophrenia. Psychiat Ann 25: 285-296

Ereshefsky L. , Lacombe S. (1993) Pharmacological profile of risperidone. Can J Psychiat 38(3): S80-S88

Ereshefsky L. , Watanabe M.D. , Tran-Johnson T. (1989) Clozapine: an atypical antipsychotic. Clin Pharmac 8: 691-709

Farber N.B. , Price M.T. , Labruyere J. , Nemnich J. , St Peter H. , Wozniak D.F. , Olney J.W. (1993) Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity. Biol Psychiat 34:119-121

10.

Grace A.A. (1992) The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. J Neural Transm 36 (Suppl.): 91-131

11.

Javitt D.C. , Zukini S.R. (1991) Recent advances in the phencyclidine model of schizophrenia . Am J Psychiat 148 : 1301-1308

12.

Joyce J.N. (1993) The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology 112: S16-S34

13.

Kane J. and the Clozaril Collaborative Group (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison versus chlorpromazine/benztropine. Archs Gen Psychiat 45: 789-796

14.

Kay S.R. (1991) Positive and negative syndromes in schizophrenia: assessment and research. In van Praag H (ed.), Clinical and experimental psychiatry. Brunner /Mazel, New York, pp. 140-193

15.

Kay S.R. , Opler L.A. (1987) The positive-negative dimension in schizophrenia: its validity and significance. Psychiat Dev 5: 79-103

16.

Liddle P.F. (1987) The symptoms of chronic schizophrenia: A reexamination of the positive-negative dichotomy. Br J Psychiat 151: 145-151

17.

Lieberman J.A. (1996) Pharmacotherapy for patients with first-episode, acute, and refractory schizophrenia. Psychiat Ann 26: 515-518

18.

Meltzer H.Y. (1991) The mechanism of action of novel antipsychotic drugs. Schizophr Bull 17: 263-287

19.

Miller A.L. , Mahurin R.K. , Velligan D.I. , Maas J.W. (1995) Negative symptoms of schizophrenia: where do we go from here? Biol Psychiat 37: 691-693

20.

OlneyJ W. , Farber N.B. (1995a) Glutamate receptor dysfunction and schizophrenia . Archs Gen Psychiat 52: 998-1007

21.

Olney J.W. , Farber N.B. (1995b) Response to commentaries and to the challenge of building a perfect theory to explain schizophrenia. Archs Gen Psychiat 52:1019-1024

22.

Siever L.J. , Davis K.L. (1985) Overview: toward a dysregulation hypothesis of depression. Am J Psychiat 142:1017-1031

23.

Skarsfeldt T. (1995) Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat. Eur J Pharmac 281: 289-294

24.

Stahl S.M. (1994) New therapeutic advances in schizophrenia. In Ancill R J , Holliday S , Higenbottam J (eds), Schizophrenia: exploring the spectrum of psychosis. John Wiley, Chichester, pp. 138-152

25.

Stern R.G. (1993) Predictors of response to neuroleptic treatment in schizophrenia. Psychiat Clin N Am 16: 313-338

26.

Suppes T. , Phillips K.A. , Judd C.R. (1994) Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases. Biol Psychiat 36: 338-340

27.

Tassin J.P. (1992) NE/DA interactions in prefrontal cortex and their possible roles as neuromodulators of schizophrenia. J Neural Transm 36 (Suppl.): 136-162

28.

Wolf M.E. , Roth R.H. (1988) Heterogeneity of midbrain dopamine neurons: implications for psychiatry. Psychiat Lett 6: 24-32